Literature DB >> 23359146

Identification and analysis of precursors to invasive pancreatic cancer.

Hanno Matthaei1, Marco Dal Molin, Anirban Maitra.   

Abstract

Precursor lesions of pancreatic cancer have been recognized about a century ago. The development of a consistent reproducible nomenclature and classification system for these lesions has been a major advance in the study of these noninvasive precursors. Pancreatic intraepithelial neoplasia (PanIN) as microscopic precursor lesions can be distinguished from mucinous cystic neoplasms (MCNs) and intraductal papillary mucinous neoplasms (IPMN) that are cystic and can often be recognized on imaging. Since precursor lesions harbor the unique chance to treat a patient before a fatal pancreatic cancer can arise a molecular characterization is essential to understand the biology and to find diagnostic and therapeutic targets to fight this disease of near uniform lethality. In order to study precursor lesions on a molecular level a meticulous isolation of the neoplastic cells is inevitable. We present the salient histopathologic and molecular features of precursor lesions of pancreatic cancer as well as methods that have proved to be useful within experimental studies.

Entities:  

Mesh:

Year:  2013        PMID: 23359146     DOI: 10.1007/978-1-62703-287-2_1

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  5 in total

1.  Preclinical Models for Studying the Impact of Macrophages on Cancer Cachexia.

Authors:  Spas Dimitrov Markov; Daisy Gonzalez; Kamiya Mehla
Journal:  Curr Protoc Pharmacol       Date:  2020-12

2.  Multi-institutional Validation Study of Pancreatic Cyst Fluid Protein Analysis for Prediction of High-risk Intraductal Papillary Mucinous Neoplasms of the Pancreas.

Authors:  Mohammad A Al Efishat; Marc A Attiyeh; Anne A Eaton; Mithat Gönen; Denise Prosser; Anna E Lokshin; Carlos Fernández-Del Castillo; Keith D Lillemoe; Cristina R Ferrone; Ilaria Pergolini; Mari Mino-Kenudson; Neda Rezaee; Marco Dal Molin; Matthew J Weiss; John L Cameron; Ralph H Hruban; Michael I D'Angelica; T Peter Kingham; Ronald P DeMatteo; William R Jarnagin; Christopher L Wolfgang; Peter J Allen
Journal:  Ann Surg       Date:  2018-08       Impact factor: 12.969

3.  Monitoring pancreatic carcinogenesis by the molecular imaging of cathepsin E in vivo using confocal laser endomicroscopy.

Authors:  Hui Li; Yongdong Li; Lei Cui; Biyuan Wang; Wenli Cui; Minghua Li; Yingsheng Cheng
Journal:  PLoS One       Date:  2014-09-03       Impact factor: 3.240

Review 4.  Deciphering the link between PI3K and PAK: An opportunity to target key pathways in pancreatic cancer?

Authors:  Kiruthikah Thillai; Hoyin Lam; Debashis Sarker; Claire M Wells
Journal:  Oncotarget       Date:  2017-02-21

5.  Case-control study of aspirin use and risk of pancreatic cancer.

Authors:  Samantha A Streicher; Herbert Yu; Lingeng Lu; Mark S Kidd; Harvey A Risch
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-07       Impact factor: 4.090

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.